A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

Last updated: February 27, 2026
Sponsor: Eli Lilly and Company
Overall Status: Active - Not Recruiting

Phase

3

Condition

Obesity

Weight Loss

Diabetes Prevention

Treatment

Placebo

Retatrutide

Clinical Study ID

NCT06859268
27268
J1I-MC-GZQB
  • Ages > 18
  • All Genders

Study Summary

This is a study of retatrutide in participants with obesity. The main purpose is to learn more about how retatrutide maintains body weight loss. The study will have two treatment phases: an 80 week lead-in phase in which all participants will take retatrutide dose 1 and a 36 week randomized, double-blinded phase in which participants will either take retatrutide dose 1, retatrutide dose 2, or switch to placebo. Participation in the study will last around 125 weeks.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Have obesity and a history of at least one self-reported unsuccessful dietary effortto reduce body weight

Exclusion

Exclusion Criteria:

  • Have a self-reported change in body weight >5 kilograms (kg) (11 pounds) within 90days before screening

  • Have a prior or planned surgical treatment for obesity

  • Have a prior or planned endoscopic procedure and/or device-based therapy for obesity

  • Have Type 1 Diabetes, Type 2 Diabetes, or any other type of diabetes

  • Have a family or personal history of medullary thyroid carcinoma (MTC) or multipleendocrine neoplasia syndrome type 2 (MEN-2)

  • Have had within the past 90 days before screening:

  • acute myocardial infarction

  • cerebrovascular accident (stroke)

  • hospitalization for unstable angina, or

  • hospitalization due to congestive heart failure

  • Have New York Heart Association Functional Classification Class IV congestive heartfailure

  • Have a history of chronic or acute pancreatitis

  • Have taken weight loss drugs, including over-the-counter medications, within 90 daysprior to screening

Study Design

Total Participants: 643
Treatment Group(s): 2
Primary Treatment: Placebo
Phase: 3
Study Start date:
March 05, 2025
Estimated Completion Date:
April 30, 2028

Connect with a study center

  • Aggarwal and Associates Limited

    Brampton, L6T 0G1
    Canada

    Site Not Available

  • Circulate Cardiac & Vascular Centre

    Burlington, L7M 1K9
    Canada

    Site Not Available

  • Med Trust Research

    Courtice, L1E 2J5
    Canada

    Site Not Available

  • Winterberry Research Inc.

    Hamilton, L8J 0B6
    Canada

    Site Not Available

  • Centre de Medecine Metabolique de Lanaudiere (CMML)

    Terrebonne, J6X 4P7
    Canada

    Site Not Available

  • Care Access - Thunder Bay - Barton Street

    Thunder Bay, P7B 7C7
    Canada

    Site Not Available

  • Maple Leaf Research

    Toronto, M5G 1K2
    Canada

    Site Not Available

  • C.I.C. Mauricie inc.

    Trois-Rivières, G8T 7A1
    Canada

    Site Not Available

  • FutureMeds - Birmingham

    Birmingham, B21 9RY
    United Kingdom

    Site Not Available

  • Oakenhurst Medical Practice

    Blackburn, BB2 1AX
    United Kingdom

    Site Not Available

  • Layton Medical Centre

    Blackpool, FY3 7EN
    United Kingdom

    Site Not Available

  • Bradford on Avon Health Centre

    Bradford-on-Avon, BA15 1DQ
    United Kingdom

    Site Not Available

  • FutureMeds - Liverpool

    Bromborough, CH62 6EE
    United Kingdom

    Site Not Available

  • Cheadle Community Hospital

    Cheadle, ST10 1NS
    United Kingdom

    Site Not Available

  • HMC Health Group - Meadows Centre for Health

    Hounslow, TW4 7NR
    United Kingdom

    Site Not Available

  • St Bartholomew's Medical Centre

    Oxford, OX4 1XB
    United Kingdom

    Site Not Available

  • Atlantic Medical

    Penzance, TR18 3DX
    United Kingdom

    Site Not Available

  • The Adam Practice

    Poole, BH16 5PW
    United Kingdom

    Site Not Available

  • Woodstock Bower Surgery

    Rotherham, S61 1AH
    United Kingdom

    Site Not Available

  • Rame Group Practice

    Torpoint, PL11 2TB
    United Kingdom

    Site Not Available

  • Southern California Clinical Research

    Santa Ana, California 92701
    United States

    Site Not Available

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado 80045
    United States

    Site Not Available

  • CMR of Greater New Haven, LLC

    Hamden, Connecticut 06517
    United States

    Site Not Available

  • ALL Medical Research, LLC

    Cooper City, Florida 33024
    United States

    Site Not Available

  • Florida International Medical Research

    Coral Gables, Florida 33134
    United States

    Site Not Available

  • Renstar Medical Research

    Ocala, Florida 34470
    United States

    Site Not Available

  • Charter Research - Winter Park

    Orlando, Florida 32803
    United States

    Site Not Available

  • Metabolic Research Institute, Inc.

    West Palm Beach, Florida 33401
    United States

    Site Not Available

  • Kubost Clinical Research - Marietta

    Marietta, Georgia 30062
    United States

    Site Not Available

  • North Georgia Clinical Research

    Woodstock, Georgia 30189
    United States

    Site Not Available

  • Pacific Diabetes & Endocrine Center

    Honolulu, Hawaii 96817
    United States

    Site Not Available

  • Alliance for Multispecialty Research, LLC

    Oak Brook, Illinois 60523
    United States

    Site Not Available

  • Springfield Clinic Main Campus

    Springfield, Illinois 62703
    United States

    Site Not Available

  • Alliance for Multispecialty Research, LLC

    Lexington, Kentucky 40509
    United States

    Site Not Available

  • L-MARC Research Center

    Louisville, Kentucky 40213
    United States

    Site Not Available

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana 70808
    United States

    Site Not Available

  • Care Access - Lake Charles (Bayou Pines)

    Lake Charles, Louisiana 70601
    United States

    Site Not Available

  • Massachusetts General Hospital

    Boston, Massachusetts 02114
    United States

    Site Not Available

  • Alliance for Multispecialty Research, LLC

    Kansas City, Missouri 64114
    United States

    Site Not Available

  • Vector Clinical Trials

    Las Vegas, Nevada 89128
    United States

    Site Not Available

  • Dent Neurosciences Research Center, Inc

    Amherst, New York 14226
    United States

    Site Not Available

  • Carteret Medical Group

    Morehead City, North Carolina 28557
    United States

    Site Not Available

  • Care Access - Raleigh

    Raleigh, North Carolina 27607
    United States

    Site Not Available

  • Tekton Research, LLC.

    Moore, Oklahoma 73160
    United States

    Site Not Available

  • Altoona Center For Clinical Research

    Duncansville, Pennsylvania 16635
    United States

    Site Not Available

  • Care Access - Rapid City

    Rapid City, South Dakota 57701
    United States

    Site Not Available

  • Alliance for Multispecialty Research, LLC

    Knoxville, Tennessee 37909
    United States

    Site Not Available

  • Care Access - Houston

    Houston, Texas 77054
    United States

    Site Not Available

  • Southern Endocrinology Associates

    Mesquite, Texas 75149
    United States

    Site Not Available

  • Sleep Therapy Research Center

    San Antonio, Texas 78229
    United States

    Site Not Available

  • National Clinical Research, Inc

    Richmond, Virginia 23294
    United States

    Site Not Available

  • Northwest Clinical Research Center

    Bellevue, Washington 98007
    United States

    Site Not Available

  • Central Washington Health Services Association d/b/a Confluence Health

    Wenatchee, Washington 98801
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.